You, Wanfang
Li, Qian
Chen, Lizhou
He, Ning
Li, Yuanyuan
Long, Fenghua
Wang, Yaxuan
Chen, Yufei
McNamara, Robert K.
Sweeney, John A.
DelBello, Melissa P.
Gong, Qiyong
Funding for this research was provided by:
National Natural Science Foundation of China (81801683, 81820108018, 82027808)
Sichuan Science and Technology Program (2023YFS0226, 23ZDYF2088)
Chengdu Technology Innovation Research and Development Project (2022-YF05-01590-SN)
National Key R&D Program of China (2022YFC2009900)
Article History
Received: 1 September 2023
Accepted: 22 February 2024
First Online: 4 March 2024
Declarations
:
: Not applicable.
: All authors read and approved the final manuscript.
: MPD receives research support from national institutes of health (NIH), PCORI, Acadia, Allergan, Janssen, Johnson and Johnson, Lundbeck, Otsuka, Pfizer, and Sunovion. She is also a consultant, on the advisory board, or has received honoraria for speaking for Alkermes, Allergan, Assurex, CMEology, Janssen, Johnson and Johnson, Lundbeck, Myriad, Neuronetics, Otsuka, Pfizer, Sunovion, and Supernus. RKM has received research support from Martek Biosciences Inc, Royal DSM Nutritional Products, LLC, Inflammation Research Foundation, Ortho-McNeil Janssen, AstraZeneca, Eli Lilly, NARSAD, and NIH, and previously served on the scientific advisory board of the Inflammation Research Foundation. Other authors declare no potential conflicts of interest with regard to this manuscript.